Doctor of chemistry and has solid experience from research in the MedTech and biotechnology sectors. Entrepreneurial experience in companies such as SpectraCure AB, Lumito AB, Gasporox AB and Prolight Diagnostics AB.
Active entrepreneur and investor for many years. Founder of Virtway Invest AB where he is also chair of the board. He has previously worked as a stockbroker.
Extensive experience in financing and developing early-stage companies. CEO of Cardeon since the company was founded.
Katarina Svanberg has an M.D., PhD and has for a long time been chief physician and adjunct professor of oncology at Lund University. She has been a part-time professor at South China Normal University in Guangzhou, China since 2011. Katarina has introduced photodynamic tumor therapy in clinical use at Lund University Hospital. She has received the US Medicines Agency’s award in laser medicine, and the optics and laser organization SPIE’s highest reward; its gold medal.
Sune Svanberg is a senior professor of physics at Lund University. He has been director of the Department of Atomic Physics for 30 years and of the Lund Laser Center for 15 years, as well as a member of the Nobel Committee in Physics for 10 years. Sune has been awarded around 20 international and national prizes and holds five honorary doctorates and four honorary professorships. Since 2011, Sune also holds a part-time professorship at South China Normal University, Guangzhou, China.
Bachelor of Arts in Chemistry and Biology, Doctor of Physiology from Uppsala university, and Associate Professor at Uppsala University. Consultant in biotechnology and finance. Has previously worked with research and business development at both Astra AB and Pharmacia AB. Thereafter, as a pharmaceutical analyst in the financial industry, e.g. at Swedbank, Aros Securities and ABG Sundal Collier. Today Chairman of the Board of, among others, Miris Holding, SpectraCure and EQL Pharma.
Professor of surgery at Lund University since 2000. Solid clinical experience and clinical and translational research. Author of more than 500 articles in peer-reviewed journals. Supervisor for about 30 completed doctoral students in the areas of cancer, systemic inflammation, organ failure and intestinal function.
Professor of Physics at Lund University until 2016. Since 2016 Director of Biophotonics at Tyndall National Institute, Ireland. Post-doc at McMasters University in Hamilton, Ontario, Canada. Received the Erna Ebeling Prize, Swedish Society for Medical Technology and Physics, 2003. Co-author of more than 200 articles in peer-reviewed journals.
Bachelor of Medicine from Karolinska Institutet, Master of Business Administration and Master from the Stockholm School of Economics. Currently CEO at Prolight Diagnostics. Has previously been i.e. General Manager, Vice President of the EMEA Region at Hycor Biomedical, Vice President Commercial Operations Europe at Thermo Fisher Scientific Immuno Diagnostics Division.
Extensive experience in commercializing research results in the role of CTO at SpectraCure and former CTO at Gasporox and GPX Medical. Expertise in product development for medical technology systems.